Chugai Pharmaceutical Statistics
Total Valuation
CHGCY has a market cap or net worth of 74.57 billion. The enterprise value is 67.93 billion.
| Market Cap | 74.57B |
| Enterprise Value | 67.93B |
Important Dates
The next estimated earnings date is Thursday, April 24, 2025.
| Earnings Date | Apr 24, 2025 |
| Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 639.64M |
Valuation Ratios
The trailing PE ratio is 30.27.
| PE Ratio | 30.27 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 6.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.77, with an EV/FCF ratio of 26.92.
| EV / Earnings | 27.57 |
| EV / Sales | 8.71 |
| EV / EBITDA | 17.77 |
| EV / EBIT | 18.80 |
| EV / FCF | 26.92 |
Financial Position
The company has a current ratio of 5.53
| Current Ratio | 5.53 |
| Quick Ratio | 4.59 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 21.96% and return on invested capital (ROIC) is 19.21%.
| Return on Equity (ROE) | 21.96% |
| Return on Assets (ROA) | 16.36% |
| Return on Invested Capital (ROIC) | 19.21% |
| Return on Capital Employed (ROCE) | 28.26% |
| Revenue Per Employee | 979,180 |
| Profits Per Employee | 323,979 |
| Employee Count | 7,604 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +17.05% in the last 52 weeks. The beta is 0.54, so CHGCY's price volatility has been lower than the market average.
| Beta (5Y) | 0.54 |
| 52-Week Price Change | +17.05% |
| 50-Day Moving Average | 23.11 |
| 200-Day Moving Average | 22.14 |
| Relative Strength Index (RSI) | 45.03 |
| Average Volume (20 Days) | 179,500 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CHGCY had revenue of 7.45 billion and earned 2.46 billion in profits. Earnings per share was 1.50.
| Revenue | 7.45B |
| Gross Profit | 5.29B |
| Operating Income | 3.45B |
| Pretax Income | 3.45B |
| Net Income | 2.46B |
| EBITDA | 3.62B |
| EBIT | 3.45B |
| Earnings Per Share (EPS) | 1.50 |
Balance Sheet
The company has 6.34 billion in cash and n/a in debt, giving a net cash position of 6.34 billion.
| Cash & Cash Equivalents | 6.34B |
| Total Debt | n/a |
| Net Cash | 6.34B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 12.09B |
| Book Value Per Share | 7.35 |
| Working Capital | 8.37B |
Cash Flow
In the last 12 months, operating cash flow was 2.85 billion and capital expenditures -323.91 million, giving a free cash flow of 2.52 billion.
| Operating Cash Flow | 2.85B |
| Capital Expenditures | -323.91M |
| Free Cash Flow | 2.52B |
| FCF Per Share | n/a |
Margins
Gross margin is 71.01%, with operating and profit margins of 46.30% and 33.09%.
| Gross Margin | 71.01% |
| Operating Margin | 46.30% |
| Pretax Margin | 46.39% |
| Profit Margin | 33.09% |
| EBITDA Margin | 48.55% |
| EBIT Margin | 46.30% |
| FCF Margin | 33.89% |
Dividends & Yields
This stock pays an annual dividend of 0.62, which amounts to a dividend yield of 2.66%.
| Dividend Per Share | 0.62 |
| Dividend Yield | 2.66% |
| Dividend Growth (YoY) | 10.19% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 34.40% |
| Buyback Yield | -0.01% |
| Shareholder Yield | 2.65% |
| Earnings Yield | 3.30% |
| FCF Yield | 3.38% |
Stock Splits
The last stock split was on July 6, 2020. It was a forward split with a ratio of 12.
| Last Split Date | Jul 6, 2020 |
| Split Type | Forward |
| Split Ratio | 12 |
Scores
CHGCY has an Altman Z-Score of 22.76.
| Altman Z-Score | 22.76 |
| Piotroski F-Score | n/a |